---
title: "301257.SZ (301257.SZ) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/301257.SZ/news.md"
symbol: "301257.SZ"
name: "301257.SZ"
parent: "https://longbridge.com/zh-CN/quote/301257.SZ.md"
datetime: "2026-03-12T05:02:16.615Z"
locales:
  - [en](https://longbridge.com/en/quote/301257.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301257.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301257.SZ/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/301257.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301257.SZ/news.md)


# 301257.SZ (301257.SZ) — 相关新闻

### [](https://longbridge.com/zh-CN/news/278812414.md)
*2026-03-12T03:16:24.000Z*
> Sources say that Singapore-based Prologis plans to conduct an initial public offering in Hong Kong, targeting a valuatio

### [New Stock News | It is reported that logistics giant Prologis plans to file with the Hong Kong Stock Exchange in the second quarter at the earliest, aiming to raise over 1 billion USD](https://longbridge.com/zh-CN/news/278466685.md)
*2026-03-10T00:50:04.000Z*
> Logistics giant Prologis plans to submit a listing application to the Hong Kong Stock Exchange in the second quarter of 

### [](https://longbridge.com/zh-CN/news/278351404.md)
*2026-03-09T07:59:18.000Z*
> Prologis plans to raise at least $1 billion through a Hong Kong IPO. (IFR)

### [ClinPlus has established a pharmaceutical technology research company in Beijing](https://longbridge.com/zh-CN/news/272634747.md)
*2026-01-15T03:04:29.000Z*
> According to the Qichacha APP, recently, Ruixin Pharmaceutical Technology Research Co., Ltd. was established, with Lai C

### [ClinPlus: The cumulative deviation of the increase exceeds 30%, and shareholders plan to collectively reduce their holdings by 1.87% of the company's shares](https://longbridge.com/zh-CN/news/272554728.md)
*2026-01-14T12:52:23.000Z*
> ClinPlus announced that due to the company's stock trading price closing price deviation exceeding 30% for two consecuti

### [ClinPlus: Huqiao Hongjia plans to reduce its holdings by no more than 0.7054%, and Zhang Jing plans to reduce his holdings by no more than 1.1605%](https://longbridge.com/zh-CN/news/272554418.md)
*2026-01-14T12:50:37.000Z*
> ClinPlus announced that the company's shareholder Shanghai Hongjia Private Fund Management Co., Ltd. - Ningbo Huqiao Hon

### [AI medical concept repeatedly active, R&G Pharma 20cm two consecutive limit-ups](https://longbridge.com/zh-CN/news/272485616.md)
*2026-01-14T02:19:47.000Z*
> The AI medical concept is repeatedly active, R&G Pharma has a two-day limit up of 20cm, ClinPlus, GOODWILL, and Winning 

### [](https://longbridge.com/zh-CN/news/272481287.md)
*2026-01-14T01:41:30.000Z*
> The A-share medical services sector opened with a continuous rise, with ClinPlus up over 14% hitting a new high during t

### [Midday limit-up and limit-down stock analysis: 81 limit-up stocks, 22 limit-down stocks, CRO/CMO concept is active, Hongbo Pharmaceutical has 2 boards in 3 days, and stocks like R&G Pharma and ClinPlus are limit-up](https://longbridge.com/zh-CN/news/272356497.md)
*2026-01-13T03:49:12.000Z*
> On January 13th at noon, the A-share market was active, with 81 stocks hitting the daily limit up and 22 stocks hitting 

### [](https://longbridge.com/zh-CN/news/272344710.md)
*2026-01-13T01:57:32.000Z*
> The A-share CRO concept continues to strengthen, with ClinPlus and Hongbo Pharmaceutical hitting the 20% limit up, HitGe